NVST logo

Envista Holdings (NVST)

Profile

Full Name

Envista Holdings Corporation

Ticker Symbol

NVST

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

September 18, 2019

Indexes

Not included

Website

http://envistaco.com

Employees

12300

Key Details

Price

$19.67(+0.10%)

Market cap

$3.33B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.51B(-2.18% YoY)

Annual EPS

-$6.50(-983.33% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $19.67
    NVST price is $19.67

    30-Day Relative Volume

    1.11
    NVST 30-day relative volume is 1.11

    Price Performance

    Price Most recent change

    +0.1%
    NVST price was up +0.1% on Jun 27, 2025

    Price YTD change

    +1.97%
    NVST price is up +1.97% since January 1st

    Price 1-year change

    +19.36%
    NVST price is up +19.36% year-on-year

    Price 3-year change

    -49.55%
    NVST price is down -49.55% over the past 3 years

    Price Range

    Price All-time high

    $52.03
    NVST price is currently -62.19% below its historical high of $52.03

    Price 3-year low

    $14.22
    NVST price is currently +38.33% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.33B
    NVST market capitalization is $3.33 billion

    Market cap 3-year change

    -47.42%
    NVST market capitalization is down -47.42% over the past 3 years

    Market cap All-time high

    $8.24B
    NVST market capitalization is currently -59.53% below its historical high of $8.24 billion

    Market cap sector rank

    86.33%
    NVST market capitalization is higher than 86.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.38%
    NVST shares outstanding is down -1.38% year-on-year

    Shares Outstanding 3-Year Change

    +4.22%
    NVST shares outstanding is up +4.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.20
    NVST beta is 1.20

    200-day SMA

    $18.87
    NVST price is currently +4.21% above its 200-day simple moving average

    50-day SMA

    $17.69
    NVST price is currently +11.19% above its 50-day simple moving average

    RSI

    64.52
    NVST 14-day relative strength index is 64.52

    Volume

    1.11
    NVST 30-day relative volume is 1.11

    ATR

    $0.57
    NVST average true range is $0.57

    10-day Historical Volatility

    29.04%
    NVST 10-day historical volatility is 29.04%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.51B
    NVST annual revenue is $2.51 billion

    Revenue Analysts estimate

    $2.55B
    NVST annual revenue is currently -1.39% lower than the consensus analysts' forecast

    Revenue 1-year change

    -2.18%
    NVST annual revenue is down -2.18% year-on-year

    Revenue Sector rank

    86.54%
    NVST annual revenue is higher than 86.54% of companies in Healthcare sector

    EPS

    EPS

    -$6.50
    NVST annual earnings per share is -$6.50

    EPS Analysts estimate

    $1.02
    NVST annual earnings per share is currently -738.88% lower than the consensus analysts' forecast

    EPS 1-year change

    -983.33%
    NVST annual earnings per share is down -983.33% year-on-year

    EPS Sector rank

    16.64%
    NVST annual earnings per share is higher than 16.64% of companies in Healthcare sector

    Profit

    Gross profit

    $1.37B
    NVST annual gross profit is $1.37 billion

    Gross margin

    54.68%
    NVST annual gross profit margin is 54.68%

    Operating profit

    $115.60M
    NVST annual operating income is $115.60 million

    Operating margin

    4.60%
    NVST annual operating profit margin is 4.60%

    Net income

    -$1.12B
    NVST annual net profit is -$1.12 billion

    Net margin

    -44.56%
    NVST annual net profit margin is -44.56%

    Expenses

    Total expenses

    $2.40B
    NVST annual total expenses is $2.40 billion

    Operating expenses

    $1.26B
    NVST annual total operating expenses is $1.26 billion

    Cost of goods sold

    $1.14B
    NVST annual cost of goods sold is $1.14 billion

    Selling, general & administrative expenses

    $1.16B
    NVST annual SGA is $1.16 billion

    Depreciation and amortization

    $154.50M
    NVST annual depreciation & amortization is $154.50 million

    Interest expense

    $46.40M
    NVST annual interest expense is $46.40 million

    Income tax

    $33.90M
    NVST annual income tax is $33.90 million

    EBIT & EBITDA

    EBIT

    -$1.04B
    NVST annual earnings before interest & taxes is -$1.04 billion

    EBITDA

    -$883.80M
    NVST annual EBITDA is -$883.80 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.35B
    NVST annual total assets is $5.35 billion

    Non current assets

    $3.56B
    NVST annual long term assets is $3.56 billion

    Current assets

    $1.79B
    NVST annual total current assets is $1.79 billion

    Cash and cash equivalents

    $1.07B
    NVST annual cash & cash equivalents is $1.07 billion

    Accounts receivable

    $363.00M
    NVST annual accounts receivable is $363.00 million

    Inventory

    $241.00M
    NVST annual inventory is $241.00 million

    Liabilities

    Total liabilities

    $2.42B
    NVST annual total liabilities is $2.42 billion

    Long term liabilities

    $1.54B
    NVST annual total long term liabilities is $1.54 billion

    Current liabilities

    $878.70M
    NVST annual total current liabilities is $878.70 million

    Accounts payable

    $174.60M
    NVST annual accounts payable is $174.60 million

    Debt

    Total debt

    $1.55B
    NVST annual total debt is $1.55 billion

    Total debt 1-year change

    -6.4%
    NVST annual total debt is down -6.4% year-on-year

    Long term debt

    $1.40B
    NVST annual long term debt is $1.40 billion

    Short term debt

    $150.50M
    NVST annual short term debt is $150.50 million

    Equity & Capital

    Shareholders equity

    $2.93B
    NVST annual stockholders equity is $2.93 billion

    Book value

    $2.93B
    NVST annual book value is $2.93 billion

    Retained earnings

    -$487.40M
    NVST annual retained earnings is -$487.40 million

    Working capital

    $909.60M
    NVST annual working capital is $909.60 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $336.50M
    NVST annual cash flow from operations is $336.50 million

    Cash from operations 1-year change

    +22.05%
    NVST annual cash flow from operations is up +22.05% year-on-year

    Cash from investing

    -$54.60M
    NVST annual cash flow from investing activities is -$54.60 million

    Cash from investing 1-year change

    +12.5%
    NVST annual cash flow from investing activities is up +12.5% year-on-year

    Cash from financing

    -$103.70M
    NVST annual cash flow from financing activities is -$103.70 million

    Cash from financing 1-year change

    -187.22%
    NVST annual cash flow from financing activities is down -187.22% year-on-year

    CAPEX

    CAPEX

    $33.80M
    NVST annual capital expenditures is $33.80 million

    CAPEX 1-year change

    -41.92%
    NVST annual capital expenditures is down -41.92% year-on-year

    Free Cash Flow

    Free cash flow

    $302.70M
    NVST annual free cash flow is $302.70 million

    Free cash flow 1-year change

    +39.17%
    NVST annual free cash flow is up +39.17% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    54.68%
    NVST annual gross profit margin is 54.68%

    Operating margin

    4.60%
    NVST annual operating profit margin is 4.60%

    Net margin

    -44.56%
    NVST annual net profit margin is -44.56%

    ROA & ROE

    ROA

    -18.71%
    NVST annual return on assets is -18.71%

    ROE

    -31.47%
    NVST annual return on equity is -31.47%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NVST price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NVST price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.10
    NVST price to book ratio is 1.10

    PB ratio Sector rank

    42.75%
    NVST price to book ratio is higher than 42.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.33
    NVST price to sales ratio is 1.33

    PS ratio Sector rank

    31.13%
    NVST price to sales ratio is higher than 31.13% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.82B
    NVST enterprise value is $3.82 billion

    Enterprise value Sector rank

    86.15%
    NVST enterprise value is higher than 86.15% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.26
    NVST EV/EBITDA is -4.26

    EV/EBITDA Sector rank

    24.63%
    NVST EV/EBITDA is higher than 24.63% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.04
    NVST annual current ratio is 2.04

    Quick ratio

    1.76
    NVST annual quick ratio is 1.76

    Leverage

    Debt to equity

    0.48
    NVST annual debt to equity ratio is 0.48

    Interest coverage ratio

    -22.38
    NVST annual interest coverage ratio is -22.38

    Risk & Stability

    Piotroski F-Score

    5
    NVST piotroski f-score is 5

    Altman Z-Score

    0.73
    NVST altman z-score is 0.73

    Analyst ratings

    Recent major analysts updates

    May 27, 25 Baird
    Outperform
    May 5, 25 UBS
    Neutral
    Apr 30, 25 Piper Sandler
    Neutral
    Apr 29, 25 B of A Securities
    Buy
    Mar 10, 25 UBS
    Neutral
    Mar 6, 25 Needham
    Hold
    Mar 6, 25 Morgan Stanley
    Equal-Weight
    Mar 6, 25 JP Morgan
    Neutral
    Feb 25, 25 Needham
    Hold
    Feb 6, 25 Wells Fargo
    Equal-Weight

    Institutional Ownership

    Screeners with NVST included

    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks recommended to hold
    Healthcare sector
    All stocks
    Stocks above analysts price target
    Companies with buyback
    Ex Dividend dates calendar
    NYSE Companies
    • What is the ticker symbol for Envista Holdings?
    • Does Envista Holdings pay dividends?
    • What sector is Envista Holdings in?
    • What industry is Envista Holdings in?
    • What country is Envista Holdings based in?
    • When did Envista Holdings go public?
    • Is Envista Holdings in the S&P 500?
    • Is Envista Holdings in the NASDAQ 100?
    • Is Envista Holdings in the Dow Jones?
    • When was Envista Holdings's last earnings report?
    • When does Envista Holdings report earnings?
    • Should I buy Envista Holdings stock now?

    What is the ticker symbol for Envista Holdings?

    The ticker symbol for Envista Holdings is NYSE:NVST

    Does Envista Holdings pay dividends?

    No, Envista Holdings does not pay dividends

    What sector is Envista Holdings in?

    Envista Holdings is in the Healthcare sector

    What industry is Envista Holdings in?

    Envista Holdings is in the Medical Instruments & Supplies industry

    What country is Envista Holdings based in?

    Envista Holdings is headquartered in United States

    When did Envista Holdings go public?

    Envista Holdings's initial public offering (IPO) was on September 18, 2019

    Is Envista Holdings in the S&P 500?

    No, Envista Holdings is not included in the S&P 500 index

    Is Envista Holdings in the NASDAQ 100?

    No, Envista Holdings is not included in the NASDAQ 100 index

    Is Envista Holdings in the Dow Jones?

    No, Envista Holdings is not included in the Dow Jones index

    When was Envista Holdings's last earnings report?

    Envista Holdings's most recent earnings report was on May 1, 2025

    When does Envista Holdings report earnings?

    The next expected earnings date for Envista Holdings is Aug 7, 2025

    Should I buy Envista Holdings stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page